Comparison of Laparoscopic Surgery Versus Open Surgery in the Treatment of Adhesive Small Bowel Obstruction

June 16, 2018 updated by: Ville Sallinen, Helsinki University Central Hospital

Laparoscopic Versus Open Adhesiolysis for Small Bowel Obstruction - A Multicenter, Prospective, Randomized, Controlled Trial

Small bowel obstruction is a common reason for surgical admission. Most common reason for small bowel obstruction is adhesions, which account up to 70-80 % of small bowel obstructions. Large proportion of adhesive small bowel obstructions may be treated nonoperatively, but up to 50-60% may need surgical intervention. Current golden standard for surgical intervention is open adhesiolysis. Recently, retrospective studies have provided encouraging results of laparoscopic adhesiolysis for small bowel obstructions. However, no prospective randomized trials have been carried out and retrospective series carries a high risk for patient selection and bias. Although in general laparoscopy has been associated with shortened hospital stay, less pain and reduced mortality, laparoscopic adhesiolysis for small bowel obstruction has been reported to cause iatrogenic small bowel lesions up to 7% of patients. Aim of the study is to compare open adhesiolysis to laparoscopic adhesiolysis. The investigators hypothesis is that laparoscopic adhesiolysis is safe, will shorten the hospital stay, and reduce mortality compared to open approach.

Study Overview

Study Type

Interventional

Enrollment

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland
        • Helsinki University Central Hospital
      • Lahti, Finland
        • Päijät-Häme Central hospital
      • Oulu, Finland
        • Oulu University Hospital
      • Tampere, Finland
        • Tampere university Hospital
      • Vaasa, Finland
        • Vaasa Central Hospital
      • Vantaa, Finland
        • Peijas Hospital
      • Bologna, Italy
        • Bologna Maggiore Hospital
      • Parma, Italy
        • Parma University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 93 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients with clinical and computed tomography-diagnosed adhesive small bowel obstruction AND
  • Obstruction is not relieved by conservative methods (nasogastric tube, NPO) including Gastrografin is not passed to colon within 8 hours (48-hour conservative treatment without Gastrografin® is allowed if Gastrografin® is contraindicated (e.g. allergy) or not available)

Exclusion Criteria:

  • Strong suspicion of strangulation or clinical peritonitis thus indicating an urgent operative intervention
  • Earlier confirmed or strongly suspected peritoneal carcinosis
  • Earlier confirmed wide diffuse adhesions of abdominal cavity
  • Earlier open surgery for endometriosis
  • Earlier generalized diffuse peritonitis (not including local peritonitis such as appendicitis)
  • Active abdominal malignancy or remission less than 10 years
  • Earlier abdominal region radiotherapy
  • Earlier obesity surgery
  • 3 or more earlier open abdominal operations (not including caesarean section(s))
  • Suspicion of other cause for obstruction than adhesions in CT-scan
  • Earlier abdominal surgical operation within 30 days
  • Earlier surgical operation for aorta or iliac vessels performed through laparotomy
  • Crohn's disease
  • Anesthesiological contraindication for laparoscopy
  • Missing informed consent
  • Age less than 18 years or over 95 years
  • Pregnancy
  • Patient living in institutional care (such as health centre ward), not including retirement homes
  • Over 1 week of hospital stay directly prior surgical consultation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Laparoscopic adhesiolysis
Active Comparator: Open adhesiolysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Post-operative hospital stay (days)
Time Frame: Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Passage of stools (post-operative days)
Time Frame: Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Commence of enteral nutrition (post-operative days)
Time Frame: Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Mortality
Time Frame: 30 days after randomization
30 days after randomization
Complications, Clavien-Dindo classification
Time Frame: 30 days after randomization
30 days after randomization
Number of participants with iatrogenic small bowel lesions
Time Frame: Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Number of participants with readmission(s)
Time Frame: 30 days after randomization
30 days after randomization
Number of participant with failure to relieve obstruction
Time Frame: Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Pain scores on the Visual Analog Scale
Time Frame: Postoperative days 1- 7 or till discharge
Postoperative days 1- 7 or till discharge
Length of epidural catheter analgesia (days)
Time Frame: Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Total need of opioids in milligrams
Time Frame: Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Length of sick leave (days)
Time Frame: Participants will be followed for the duration of sick leave, depending on occupation estimated 1-4 weeks
Participants will be followed for the duration of sick leave, depending on occupation estimated 1-4 weeks
Number of participants that develop ventral hernia
Time Frame: 10 years
10 years
Number of patient with recurrent adhesive small bowel obstruction
Time Frame: 10 years
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ville Sallinen, MD, PhD, Helsinki University Central Hospital
  • Study Director: Panu Mentula, MD, PhD, Helsinki University Central Hospital
  • Study Chair: Ari Leppäniemi, MD, PhD, Helsinki University Central Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

May 26, 2013

First Submitted That Met QC Criteria

May 29, 2013

First Posted (Estimate)

June 4, 2013

Study Record Updates

Last Update Posted (Actual)

June 19, 2018

Last Update Submitted That Met QC Criteria

June 16, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • HUCH-95-150513

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Small Bowel Obstruction

Clinical Trials on Laparoscopic adhesiolysis

3
Subscribe